Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FE7F0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,197
Award facts
- Contract value 100% obligated
- $10,196.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,196.60 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen auto-injectors on November 20, 2025, with completion scheduled for November 21, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Zepbound is a GLP-1 receptor agonist primarily indicated for weight management in patients with obesity or overweight conditions, reflecting the Defense Health Agency's medical supply needs for service members and eligible beneficiaries. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling recurring demand for specialty medications across therapeutic domains. The competitively awarded contract demonstrates the contractor's capability to meet federal procurement requirements through the DLA's established prime vendor program, which enables flexible sourcing of pharmaceutical products to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FE7F0?
SPE2DR26FE7F0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FE7F0 worth?
The government has obligated $10,197 on SPE2DR26FE7F0.
Is contract SPE2DR26FE7F0 an order under another contract?
Yes. SPE2DR26FE7F0 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE7F0 competed?
The extent of competition for SPE2DR26FE7F0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award